Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $30.40 USD
Change Today -0.55 / -1.78%
Volume 402.9K
OVAS On Other Exchanges
Symbol
Exchange
NASDAQ GM
As of 8:10 PM 04/24/15 All times are local (Market data is delayed by at least 15 minutes).

ovascience inc (OVAS) Snapshot

Open
$30.97
Previous Close
$30.95
Day High
$31.46
Day Low
$30.04
52 Week High
03/25/15 - $55.69
52 Week Low
05/9/14 - $5.51
Market Cap
826.7M
Average Volume 10 Days
620.5K
EPS TTM
$-2.16
Shares Outstanding
27.2M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for OVASCIENCE INC (OVAS)

Related News

No related news articles were found.

ovascience inc (OVAS) Related Businessweek News

No Related Businessweek News Found

ovascience inc (OVAS) Details

OvaScience, Inc., a life science company, engages in the discovery, development, and commercialization of new treatments for infertility. The company’s patented technology is based on the discovery of egg precursor (EggPC) cells, which are immature egg cells found in the protective outer layer of a woman's own ovaries. It is developing and commercializing various fertility treatment options designed to enhance egg health and revolutionize in vitro fertilization (IVF) comprising AUGMENT to improve the energy and health of the woman’s eggs by using mitochondria from a woman's EggPC cells; OvaPrime treatment for boosting a woman's egg reserve by transferring the EggPCs from woman's own ovaries; OvaTure to create mature fertilizable eggs from a woman’s own EggPC cells without the need for hormone injections; and OvaXon for the prevention of genetic disease and animal health. The company was formerly known as Ovastem, Inc. and changed its name to OvaScience, Inc. in May 2011. OvaScience, Inc. was founded in 2011 and is based in Cambridge, Massachusetts.

52 Employees
Last Reported Date: 03/16/15
Founded in 2011

ovascience inc (OVAS) Top Compensated Officers

Co-Founder, Chief Executive Officer and Direc...
Total Annual Compensation: --
President and Chief Scientific Officer
Total Annual Compensation: $644.0K
Chief Commercial Officer
Total Annual Compensation: $21.1K
Compensation as of Fiscal Year 2014.

ovascience inc (OVAS) Key Developments

OvaScience, Inc. - Special Call

OvaScience, Inc. - Special Call

OvaScience, Inc. Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Year Ended December 31, 2014

OvaScience, Inc. reported unaudited consolidated earnings results for the fourth quarter and year ended December 31, 2014. Net loss for the three months ended December 31, 2014 was $18.9 million or $0.79 per share, as compared to net loss of $11.0 million or $0.64 per share, for the three months ended December 31, 2013. Loss from operations was $18.289 million against $11.013 million a year ago. Net loss for the year ended December 31, 2014 was $49.5 million or $2.19 per share, as compared to net loss of $29.0 million, or $1.80 per share, for the year ended December 31, 2013. The annual increase is primarily attributable to stock-based compensation, planned higher personnel costs, and costs associated with the launch of the AUGMENT treatment in select international regions. Loss from operations was $47.933 million against $29.134 million a year ago.

OvaScience, Inc. Presents at Credit Suisse One-on-One Healthcare Conference, Mar-03-2015

OvaScience, Inc. Presents at Credit Suisse One-on-One Healthcare Conference, Mar-03-2015 . Venue: London, United Kingdom.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OVAS:US $30.40 USD -0.55

OVAS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for OVAS.
View Industry Companies
 

Industry Analysis

OVAS

Industry Average

Valuation OVAS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 13.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OVASCIENCE INC, please visit www.ovascience.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.